Kin Yip Leung

Director/Board Member at NOVOCURE LIMITED

Net worth: 2 M $ as of 30/06/2026

64 year

78 connections

Health Technology

Consumer Services

Commercial Services

Profile

Kin Yip Leung is currently an Independent Director at NovoCure Ltd. since 2011.
Former roles include Independent Director at Curia Global, Inc. from 2010 to 2016; Director at Delcath Systems, Inc. in 2014; Director at NanoMed Pharmaceuticals, Inc.; Independent Non-Executive Director at Pernix Therapeutics Holdings, Inc. from 2016 to 2019; Principal at Bristol Myers Squibb Co. from 1990 to 1999; EVP, President-Oncology & Diabetes Business at OSI Pharmaceuticals, Inc. from 2003 to 2010; Group Vice President-Global Prescription Business at Pharmacia Corp.
from 1999 to 2003; and Member at C-Change.
Education includes undergraduate studies at The University of Texas at Austin and graduate studies at the University of Wisconsin.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
NOVOCURE LTD. 0.09%	03/06/2026	101,109 ( 0.09% )	2 M $	30/06/2026

Kin Yip Leung active positions

Companies	Position	Start
NOVOCURE LIMITED	Director/Board Member	05/08/2011

All active positions of Kin Yip Leung

Former positions of Kin Yip Leung

Companies	Position	End
PERNIX THERAPEUTICS HOLDINGS INC	Director/Board Member	09/05/2019
ALBANY MOLECULAR RESEARCH, INC.	Director/Board Member	04/02/2016
DELCATH SYSTEMS, INC.	Chairman	15/09/2014
OSI PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/01/2010
Pharmacia Corp. Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals	Corporate Officer/Principal	01/04/2003

See the detail of Kin Yip Leung's experience

Training of Kin Yip Leung

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kin Yip Leung's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Bristol Myers Squibb Co. Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products	Health Technology
OSI Pharmaceuticals, Inc. OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs	Health Technology
Curia Global, Inc. Curia Global, Inc. BiotechnologyHealth Technology Operates as a global contract research and manufacturing company that provides drug discovery, development & production services	Health Technology
Delcath Systems, Inc. Delcath Systems, Inc. Medical SpecialtiesHealth Technology Develops and manufactures drugs for treatment of cancer	Health Technology
NanoMed Pharmaceuticals, Inc. NanoMed Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic and diagnostic products	Commercial Services
Pharmacia Corp. Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals	Health Technology
The University of Texas at Austin The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Wisconsin University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
C-Change C-Change Other Consumer ServicesConsumer Services C-Change is a private company based in Washington, DC. C-Change was founded by Kevin Sharps, Lynn L. Davison.	Consumer Services
NovoCure Ltd. NovoCure Ltd. Medical SpecialtiesHealth Technology Operates as a commercial-stage oncology company	Health Technology
Pernix Therapeutics Holdings, Inc. Pernix Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products	Health Technology